XERIS PHARMACEUTICALS INC

CUSIP: 98422L107 Class: COM

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 26,532 Value ($000) $65 Avg Close Range
Q2 2021
Shares 5,891 Value ($000) $24 Avg Close Range
Q1 2021
Shares 216,831 Value ($000) $978 Avg Close Range
Q4 2020
Shares 12,038 Value ($000) $59 Avg Close Range
Q3 2020
Shares 8,079 Value ($000) $48 Avg Close Range
Q2 2020
Shares 15,922 Value ($000) $42 Avg Close Range
Q1 2020
Shares 29,844 Value ($000) $58 Avg Close Range
Q4 2019
Shares 43,613 Value ($000) $307 Avg Close Range
Q3 2019
Shares 28,152 Value ($000) $277 Avg Close Range
Q2 2019
Shares 14,102 Value ($000) $161 Avg Close Range
Q1 2019
Shares 9,396 Value ($000) $94 Avg Close Range
Q4 2018
Shares 9,396 Value ($000) $160 Avg Close Range
Q3 2018
Shares 2,324 Value ($000) $41 Avg Close Range
Q2 2018
Shares 466 Value ($000) $9 Avg Close Range